Search

everythinglearnresearchcommunity

for

Search:↓

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Ritlecitinib can help about 14,000 people with severe hair loss.

Middle Eastern patients with epidermolysis bullosa show specific genetic mutations linked to different types of the disease.

New methods can better classify curly hair types and lead to improved hair care products.

A new system for classifying curly hair types using precise measurements can improve hair care products and cultural inclusion.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

New methods to classify curly hair types were developed based on shape and strength.

The research found a way to grow plant tissue and analyze compounds in Bituminaria bituminosa, which is promising for hair restoration treatments.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Asymmetric hair follicle differentiation causes the unique shape of kinky hair.

Green tea's EGCG has various health benefits, including antioxidant properties, skin protection, cancer cell growth inhibition, anti-inflammatory effects, fat breakdown, detoxification, diabetes management, hair growth stimulation, and prevention of gum disease.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Skin cancer involves complex mechanisms, risk factors, and can be potentially prevented with strategies like dietary changes and certain compounds.

Researchers found 19 genes important for root hair growth in a plant called Arabidopsis.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Involucrin gene expression is controlled by specific proteins and signaling pathways.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.